Lymphangioleiomyomatosis clinical trials

Explore recruiting lymphangioleiomyomatosis clinical trials.

Recruiting lymphangioleiomyomatosis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Lymphangioleiomyomatosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase-II randomized clinical trial to evaluate the effect of Loratadine associated with Rapamune on Lymphagioleiomyomatosis (LAM).

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Lymphangioleiomyomatosis trials by city

Lymphangioleiomyomatosis in Toronto Lymphangioleiomyomatosis in Vancouver Lymphangioleiomyomatosis in Montreal Lymphangioleiomyomatosis in Calgary Lymphangioleiomyomatosis in Edmonton Lymphangioleiomyomatosis in Ottawa Lymphangioleiomyomatosis in Winnipeg Lymphangioleiomyomatosis in Quebec City Lymphangioleiomyomatosis in Hamilton Lymphangioleiomyomatosis in Kitchener Lymphangioleiomyomatosis in London Lymphangioleiomyomatosis in Halifax Lymphangioleiomyomatosis in New York Lymphangioleiomyomatosis in Los Angeles Lymphangioleiomyomatosis in Chicago Lymphangioleiomyomatosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease